Mayo, Wilson M.
HRN: 18-26-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2022
CEFTRIAXONE 1G (VIAL)
06/29/2022
07/05/2022
IVTT
2g
Q24
Pulmonary Infiltrates
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes